Developing computational algorithms & machine-learning techniques, to transform cross-sectional imaging data to a longitudinal picture and reconstruct the sequence of disease progression.
Check out the “booths” in this new section of the AlzForum to learn about products and services that could accelerate your research.
Brush, Floss, Take a Protease Inhibitor? Do periodontal bacteria cause some cases of Alzheimer’s disease? Scientists at one start-up think so.
In AD, tau tangles correlate closely with neurodegeneration, but how they work their mischief remains unclear… or does it?
Around 140 scientists gathered in Rungstedgaard, north of Copenhagen, Denmark, May 5–9 for the biannual Brain Conference organised by the Federation of European Neuroscience Societies and the Lundbeck Foundation. This article from the Alz Forum shares news from the event.
Merck shook the field with news that people on verubecestat scored worse than those on placebo – find out more in this post from AlzForum
GV-971, aka oligomannate, receives conditional approval in China for the treatment of mild to moderate Alzheimer’s disease.
3 years ago Michal Schwartz at the Weizmann Institute of Science, deployed an immune-boosting approach pioneered for cancer in a mouse model of Alzheimer’s disease. How has this progressed?
Researchers from University College London have strengthened the case that certain medical procedures can transfer amyloid pathology between people.
In the January 11 Science, Yigong Shi, Tsinghua University, Beijing, and colleagues present a high-resolution cryo-electron microscopy structure of γ-secretase enfolding a fragment of APP. Find out more on their work from this post on the Alz Forum.
For everything there is a season—perhaps even cognition?
https://www.alzforum.org/news/research-news/does-daytime-drowsiness-foreshadow-av-accumulation